AddLife’s acquisition of Wellspect HealthCare’s surgery and respiratory medicine has been completed
On 19 December 2018 AddLife signed an agreement on the acquisition of Wellspect HealthCare’s business in the surgery and respiration product areas. The acquisition has been completed and becomes effective as of today, 30 April 2019.AddLife is acquiring a range of market-leading niche products with associated rights and customer agreements on several geographic markets. The deal means that AddLife is making further inroads in new geographic markets. The business has net sales of around EUR 17 million, with eight markets in Europe and Australia accounting for more than 90 percent of sales.